Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 20/20 | 0.57 |
| ▸ | CBL | P22681 | 18/20 | 0.57 |
| ▸ | CBLC | Q9ULV8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22850264 | 1.00 | CBLB (0.57) | CBLBCBLCBLC | |
| SCHEMBL22849886 | 1.00 | CBLB (0.57) | CBLBCBLCBLC | |
| SCHEMBL30520987 | 0.91 | CBLB (0.49) | CBLBCBLCBLC | |
| SCHEMBL22832670 | 0.89 | CBLB (0.46) | CBLBCBLCBLC | |
| SCHEMBL25173620 | 0.89 | CBLB (0.46) | CBLBCBLCBLC | |
| SCHEMBL25179668 | 0.89 | CBLB (0.46) | CBLBCBLCBLC | |
| SCHEMBL25311764 | 0.89 | CBLB (0.47) | CBLBCBLCBLC | |
| SCHEMBL22851384 | 0.89 | CBLB (0.46) | CBLBCBLCBLC | |
| SCHEMBL25192736 | 0.89 | CBLB (0.47) | CBLBCBLCBLC | |
| SCHEMBL25311818 | 0.89 | CBLB (0.47) | CBLBCBLCBLC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4490152-A1 | ACTIVATORS OF EFFECTOR T CELLS | Orum Therapeutics Inc. (KR) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024255762-A1 | CBL-B INHIBITOR | 上海齐鲁制药研究中心有限公司 | 2024-12-19 | — | — | WO | disclosed |
| CN-117858865-A | CBL-B modulators and uses thereof | 林伯士克莱奥公司 | 2024-04-09 | — | — | CN | disclosed |
| WO-2023170608-A1 | ACTIVATORS OF EFFECTOR T CELLS | ORUM THERAPEUTICS, INC. (KR) | 2023-09-14 | — | — | WO | disclosed |